Breast cancer, Internal medicine, Genome-wide association study, Oncology and Genetics are her primary areas of study. Her study with Breast cancer involves better knowledge in Cancer. Her study on Internal medicine is mostly dedicated to connecting different topics, such as Endocrinology.
Her Genome-wide association study research is multidisciplinary, incorporating perspectives in Genotyping, Genetic association and Bioinformatics. Her Oncology research is multidisciplinary, relying on both TOX3, Serous fluid, Proportional hazards model, Triple-negative breast cancer and Prostate cancer. Her study focuses on the intersection of Genetics and fields such as Cancer research with connections in the field of Metastasis and Tumor progression.
Jenny Chang-Claude mainly focuses on Internal medicine, Oncology, Breast cancer, Colorectal cancer and Cancer. Her work deals with themes such as Single-nucleotide polymorphism and Genotype, which intersect with Internal medicine. In her study, Serous fluid is inextricably linked to Ovarian cancer, which falls within the broad field of Oncology.
Her Breast cancer research includes themes of Endocrinology, Gynecology, Cohort study and Risk factor. The study incorporates disciplines such as Gastroenterology, Cancer research, Microsatellite instability and Stage in addition to Colorectal cancer. She has researched Cancer in several fields, including Lung cancer, Mendelian randomization and Cohort.
Jenny Chang-Claude mostly deals with Internal medicine, Oncology, Colorectal cancer, Breast cancer and Odds ratio. Her Internal medicine course of study focuses on Single-nucleotide polymorphism and Ovarian cancer. Her work is dedicated to discovering how Oncology, Genome-wide association study are connected with Genetic association, Medical genetics and Germline and other disciplines.
Her Colorectal cancer research incorporates elements of Cancer research, Mendelian randomization, Epidemiology, Microsatellite instability and Disease. Jenny Chang-Claude studies Estrogen receptor which is a part of Breast cancer. Her Odds ratio study combines topics in areas such as Logistic regression, Lower risk, Menarche, Obstetrics and Confounding.
Her main research concerns Internal medicine, Oncology, Colorectal cancer, Genome-wide association study and Breast cancer. Her study in Internal medicine concentrates on Odds ratio, Cancer, Case-control study, Prospective cohort study and Confidence interval. Her Oncology research integrates issues from Epidemiology, Proportional hazards model, Disease, Hazard ratio and Stage.
Her Colorectal cancer research incorporates themes from Population study, Microsatellite instability, Aspirin, Cohort and Cancer immunology. Her work carried out in the field of Genome-wide association study brings together such families of science as Genetic association and Medical genetics. Her research integrates issues of CHEK2, Radiation therapy and Prostate cancer in her study of Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations
Hanne Meijers-Heijboer;Ans van den Ouweland;Jan Klijn;Marijke Wasielewski.
Nature Genetics (2002)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.
N Hamajima;K Hirose;K Tajima;T Rohan.
British Journal of Cancer (2002)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies.
Celeste Leigh Pearce;Claire Templeman;Mary Anne Rossing;Alice Lee.
Lancet Oncology (2012)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang;Jenny Chang-Claude;Ellen L. Goode;Fergus J. Couch.
Journal of the National Cancer Institute (2011)
Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype
Sunil R. Lakhani;Jorge S. Reis-Filho;Laura Fulford;Frederique Penault-Llorca.
Clinical Cancer Research (2005)
Protection From Colorectal Cancer After Colonoscopy: A Population-Based, Case–Control Study
Hermann Brenner;Jenny Chang-Claude;Christoph M. Seiler;Alexander Rickert.
Annals of Internal Medicine (2011)
Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations
Sunil R. Lakhani;Jocelyne Jacquemier;John P Sloane;Barry A. Gusterson.
Journal of the National Cancer Institute (1998)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: